Talor Eyal

Avg. Two Year Performance

(17%) Avg. Purchase Return
(8%) Compound
23% Avg. Sale Return
11% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return18%(2%)16%(2%)(17%)
Purchase Success Rate2 of 42 of 41 of 41 of 41 of 4
Average Sale Return2%(2%)(16%)17%23%
Sale Success Rate5 of 85 of 83 of 85 of 84 of 8
Drugs » Biotechnology

Chief Scientific Officer:

Holdings: 118.6K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--